3BBLACKBIO Share Price Target 2040

CAGR-based price projection for 3B Blackbio Dx Limited (3BBLACKBIO) targeting 2040, derived from official NSE exchange closing prices.

Bear Case (10.6% CAGR)
Rs 6,746
2040 Target
Base Case (26.5% CAGR)
Rs 44,211
2040 Target
Bull Case (78.0% CAGR)
Rs 5,279,915
2040 Target

Current Market Snapshot

CMP: Rs 1,646.80
52W High: Rs 1,710.40
52W Low: Rs 1,102.80
1Y CAGR: 60.0%
3Y CAGR: 26.5%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 1,821 Rs 2,083 Rs 2,931
2028 Rs 2,014 Rs 2,635 Rs 5,218
2029 Rs 2,228 Rs 3,333 Rs 9,288
2030 Rs 2,464 Rs 4,216 Rs 16,533
2031 Rs 2,725 Rs 5,333 Rs 29,429
2032 Rs 3,014 Rs 6,746 Rs 52,385
2033 Rs 3,333 Rs 8,533 Rs 93,247
2034 Rs 3,686 Rs 10,793 Rs 165,982
2035 Rs 4,077 Rs 13,652 Rs 295,453
2036 Rs 4,509 Rs 17,269 Rs 525,916
2037 Rs 4,987 Rs 21,844 Rs 936,147
2038 Rs 5,515 Rs 27,631 Rs 1,666,371
2039 Rs 6,100 Rs 34,951 Rs 2,966,192
2040 Rs 6,746 Rs 44,211 Rs 5,279,915

Other 3BBLACKBIO Price Targets

2025 2026 2027 2028 2030 2035 2050

Frequently Asked Questions

What is the 3BBLACKBIO share price target for 2040?

Based on historical growth analysis, the 3BBLACKBIO share price target for 2040 ranges from Rs 6,746 (conservative) to Rs 44,211 (base case) to Rs 5,279,915 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of 3BBLACKBIO?

The current market price of 3BBLACKBIO (3B Blackbio Dx Limited) is Rs 1,646.80. The 52-week high is Rs 1,710.40 and 52-week low is Rs 1,102.80.

Is 3BBLACKBIO a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for 3BBLACKBIO price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 10.6% CAGR), Base (26.5% CAGR), and Bull (optimistic at 78.0% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.